Search

Your search keyword '"Futreal P"' showing total 1,647 results

Search Constraints

Start Over You searched for: Author "Futreal P" Remove constraint Author: "Futreal P"
1,647 results on '"Futreal P"'

Search Results

1. Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer

2. Author Correction: Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma

5. METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics

7. Author Correction: Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy

9. Comprehensive characterization of IFNγ signaling in acute myeloid leukemia reveals prognostic and therapeutic strategies

10. A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma

11. Whole genome DNA copy number changes identified by high density oligonucleotide arrays

12. The “Great Debate” at Immunotherapy Bridge 2021, December 1st–2nd, 2021

13. Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression

14. Epigenomic and Transcriptomic Profiling of Solitary Fibrous Tumors Identifies Site-Specific Patterns and Candidate Genes Regulated by DNA Methylation

16. Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer

17. Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance

18. PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinoma

20. T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis

21. Complete loss of TP53 and RB1 is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcoma

22. Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy

23. Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer

26. Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non–Small Cell Lung Cancer

27. Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk

28. Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma

29. Efficacy and predictors of response of lenalidomide and rituximab in patients with treatment-naive and relapsed CLL

30. Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms

31. Immunogenomic profiling of lung adenocarcinoma reveals poorly differentiated tumors are associated with an immunogenic tumor microenvironment

32. Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

33. Genomic analysis defines clonal relationships of ductal carcinoma in situ and recurrent invasive breast cancer

34. A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia

35. Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib

36. Patient–reported fatigue prior to treatment is prognostic of survival in patients with acute myeloid leukemia

37. Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets

38. Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma

40. Metagenomes of rectal swabs in larger, advanced stage cervical cancers have enhanced mucus degrading functionalities and distinct taxonomic structure

42. Multi-modal molecular programs regulate melanoma cell state

44. Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy

45. The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma

46. Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors

48. Clonal evolution of hematopoietic stem cells after cancer chemotherapy

Catalog

Books, media, physical & digital resources